Subscribe to
this category
r

Deals

A total of 31 posts are filed under Deals
Sangamo and Pfizer to Collaborate on Development of Gene Therapy for ALS
Rare Daily Staff Sangamo Therapeutics and Pfizer said they will collaborate to develop a potential gene therapy using zinc finger protein… Continue Reading
Albireo Enters Royalty Monetization Agreement with HealthCare Royalty Partners for Constipation Drug in Japan
  Albireo Pharma said its subsidiary Elobix AB has entered into an agreement with HealthCare Royalty Partners to monetize its royalty… Continue Reading
Mallinckrodt to Acquire Sucampo Pharmaceuticals for $1.2 Billion
Rare Daily Staff Specialty pharmaceutical company Mallinckrodt said it agreed to acquire rare disease drug developer Sucampo Pharmaceuticals… Continue Reading
Array Spins Out Yarra Therapeutics to Develop Drugs for Rare Diseases
Rare Daily Staff Array BioPharma, in a filing with the U.S. Securities and Exchange Commission, said it spun out its experimental therapy to… Continue Reading
Why the Microbiome May Provide a Novel Approach to Treating Certain Rare Diseases
The microbiome has become an area of great interest among drug developers as a way to treat diseases. Synlogic, which is developing a new… Continue Reading
Orchard Therapeutics Enters Gene Therapy alliance with Généthon for Rare Immune Deficiency
Rare Daily Staff Orchard Therapeutics said it entered into a strategic alliance with Généthon, the non-profit research and development… Continue Reading
Ultragenyx Sells Priority Review Voucher for $130 million
Rare Daily Staff Rare disease drugmaker Ultragenyx Pharmaceutical said it has entered into a definitive agreement to sell its Rare Pediatric… Continue Reading
1 2 3 5